MedTrace Logo

Implementability and Effectiveness of the Safety Planning Intervention for Suicidal Behavior

NCT04230434 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 58

Last updated 2025-09-11

No results posted yet for this study

Summary

The Safety Plan Intervention (SPI) has demonstrated to reduce suicide reattempts and to increase the ambulatory follow-up in american war veterans. This study evaluates the implementability and effectiveness in a significantly different population in a real world setting.

Conditions

Interventions

BEHAVIORAL

Safety Plan Intervention

The SPI has 6 key steps: (1) identify personalized warning signs for an impending suicide crisis; (2) determine internal coping strategies that distract from suicidal thoughts and urges; (3) identify family and friends who are able to distract from suicidal thoughts and urges and social places that provide the opportunity for interaction; (4) identify individuals who can help provide support during a suicidal crisis; (5) list mental health professionals and urgent care services to contact during a suicidal crisis; and (6) lethal means counseling for making the environment safer (Stanley \& Brown, 2012)

Sponsors & Collaborators

  • Hospital Universitario La Paz

    collaborator OTHER

  • Fundacion para la Investigacion Biomedica del Hospital Universitario la Paz

    collaborator OTHER

  • Instituto de Investigación Hospital Universitario La Paz

    lead OTHER

Principal Investigators

  • Beatriz Rodriguez Vega, PhD · Instituto de Investigación Hospital Universitario La Paz

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-08-01
Primary Completion
2020-01-01
Completion
2020-02-01

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04230434 on ClinicalTrials.gov